Atlas Trials

A Phase I Study to Evaluate Safety, Tolerability in Adults With Lymphoma

Clinical trial NCT00538096 · WITHDRAWN

Trial details

NCT number
NCT00538096
Sponsor
MedImmune LLC
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Lymphoma, B-CellLymphoma, Non-Hodgkin
Start date
2007-09-01
Primary completion
2010-03-01
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.